S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
Log in
NYSE:NGVT

Ingevity Stock Forecast, Price & News

$60.11
-0.50 (-0.82 %)
(As of 10/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$60.09
Now: $60.11
$61.48
50-Day Range
$48.21
MA: $56.04
$62.30
52-Week Range
$24.92
Now: $60.11
$94.67
Volume211,658 shs
Average Volume440,404 shs
Market Capitalization$2.48 billion
P/E Ratio13.95
Dividend YieldN/A
Beta2.3
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, Europe, the Asia-Pacific, and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment develops, manufactures, and sells a range of specialty chemicals derived from co-products of the kraft pulping process and caprolactone monomers. This segment's products are used in various applications comprising pavement preservation, pavement adhesion promotion, and warm mix paving; oil well service additives, oil production, and downstream application chemicals; printing inks, adhesives, agrochemicals, lubricants, and industrial intermediates; and coatings, resins, elastomers, and bio-plastics. Ingevity Corporation was incorporated in 2015 and is headquartered in North Charleston, South Carolina.
Read More
Ingevity logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.69 out of 5 stars

Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustryN/A
Previous SymbolNASDAQ:NGVT
CUSIPN/A
Phone843-740-2300
Employees1,850

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.29 billion
Cash Flow$7.01 per share
Book Value$12.69 per share

Profitability

Net Income$183.70 million

Miscellaneous

Market Cap$2.48 billion
Next Earnings Date2/1/2021 (Estimated)
OptionableOptionable
$60.11
-0.50 (-0.82 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NGVT News and Ratings via Email

Sign-up to receive the latest news and ratings for NGVT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Ingevity (NYSE:NGVT) Frequently Asked Questions

How has Ingevity's stock price been impacted by Coronavirus (COVID-19)?

Ingevity's stock was trading at $38.80 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, NGVT shares have increased by 54.9% and is now trading at $60.11.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Ingevity?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Ingevity
.

When is Ingevity's next earnings date?

Ingevity is scheduled to release its next quarterly earnings announcement on Monday, February 1st 2021.
View our earnings forecast for Ingevity
.

How can I listen to Ingevity's earnings call?

Ingevity will be holding an earnings conference call on Wednesday, October 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Ingevity's earnings last quarter?

Ingevity Co. (NYSE:NGVT) issued its quarterly earnings data on Tuesday, October, 20th. The company reported $1.79 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.01 by $0.78. Ingevity had a return on equity of 36.42% and a net margin of 13.89%.
View Ingevity's earnings history
.

What guidance has Ingevity issued on next quarter's earnings?

Ingevity issued an update on its third quarter earnings guidance on Tuesday, October, 20th. The company provided earnings per share guidance of $1.79 for the period, compared to the Thomson Reuters consensus estimate of $1.01. The company issued revenue guidance of $332 million, compared to the consensus revenue estimate of $312.90 million.

What price target have analysts set for NGVT?

7 equities research analysts have issued twelve-month target prices for Ingevity's stock. Their forecasts range from $55.00 to $94.00. On average, they expect Ingevity's stock price to reach $71.86 in the next year. This suggests a possible upside of 19.5% from the stock's current price.
View analysts' price targets for Ingevity
.

Who are some of Ingevity's key competitors?

What other stocks do shareholders of Ingevity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ingevity investors own include Pfizer (PFE), AbbVie (ABBV), General Electric (GE), Verizon Communications (VZ), Westrock (WRK), Abbott Laboratories (ABT), The Boeing (BA), Costco Wholesale (COST), Dominion Energy (D) and Johnson & Johnson (JNJ).

Who are Ingevity's key executives?

Ingevity's management team includes the following people:
  • Mr. John C. Fortson, Pres, CEO, Interim CFO, Interim Treasurer & Director (Age 53, Pay $1.01M)
  • Mr. Stuart Edward Woodcock Jr., Exec. VP & Pres of Performance Materials (Age 54, Pay $817.88k)
  • Mr. Michael P. Smith, Exec. VP and Pres of Performance Chemicals, Strategy & Bus. Devel. (Age 59, Pay $689.98k)
  • Mr. Phillip John Platt, Chief Accounting Officer & Corp. Controller (Age 39)
  • Mr. Daniel Gallagher, VP of Investor Relations

What is Ingevity's stock symbol?

Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."

Who are Ingevity's major shareholders?

Ingevity's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include LSV Asset Management (2.95%), Patten & Patten Inc. TN (0.34%), Hodges Capital Management Inc. (0.14%), Envestnet Asset Management Inc. (0.05%), Nisa Investment Advisors LLC (0.03%) and Pacer Advisors Inc. (0.02%). Company insiders that own Ingevity stock include D Michael Wilson, Diane H Gulyas, Frederick J Lynch, John C Fortson, Katherine Pryor Burgeson, Michael P Smith, Phillip John Platt, Richard B Kelson and Stuart Edward Jr Woodcock.
View institutional ownership trends for Ingevity
.

Which institutional investors are selling Ingevity stock?

NGVT stock was sold by a variety of institutional investors in the last quarter, including Hodges Capital Management Inc., Patten & Patten Inc. TN, State of Alaska Department of Revenue, and Envestnet Asset Management Inc..
View insider buying and selling activity for Ingevity
.

Which institutional investors are buying Ingevity stock?

NGVT stock was purchased by a variety of institutional investors in the last quarter, including LSV Asset Management, Pacer Advisors Inc., and Nisa Investment Advisors LLC. Company insiders that have bought Ingevity stock in the last two years include D Michael Wilson, Diane H Gulyas, Frederick J Lynch, John C Fortson, Michael P Smith, and Richard B Kelson.
View insider buying and selling activity for Ingevity
.

How do I buy shares of Ingevity?

Shares of NGVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Ingevity's stock price today?

One share of NGVT stock can currently be purchased for approximately $60.11.

How big of a company is Ingevity?

Ingevity has a market capitalization of $2.48 billion and generates $1.29 billion in revenue each year. The company earns $183.70 million in net income (profit) each year or $4.93 on an earnings per share basis. Ingevity employs 1,850 workers across the globe.

What is Ingevity's official website?

The official website for Ingevity is www.ingevity.com.

How can I contact Ingevity?

Ingevity's mailing address is 4920 O`Hear Avenue Suite 400, North Charleston SC, 29406. The company can be reached via phone at 843-740-2300 or via email at [email protected]

This page was last updated on 10/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.